Among the significant innovations featured at the conclave were 13 herbal products developed by CSIR, including the anti-diabetic formulation BGR-34, derived from six time-tested herbs—namely Daruharidra, Giloy, Vijaysar, Gudmar, Manjistha, and Methi. The ayurvedic drug, scientifically validated by scientists from CSIR labs NBRI and CIMAP, is being seen not just as a way of managing blood sugar levels but also as a potential long-term aid in reversing diabetes. Meanwhile, Paclitaxel, derived from Arjuna tree bark, is for blood cancer, and Picroliv is aimed at treating fatty liver and liver cancer.